| September, 2021 |
The former Saitama factory of Kayaku Company Limited newly started operation as Sun Pharma Japan Technical Operations Limited. Continues to manufacture Lulicon® and other Sun Pharma topical products. |
|---|---|
| April, 2021 |
Succeeded manufacturing and marketing authorization for Gemcitabine from Taiho Pharmaceutical Company Limited and began sales in June 2021 |
| December, 2020 |
Succeeded manufacturing and marketing authorization for Irinotecan from Taiho Pharmaceutical Company Limited and began sales |
| September, 2020 |
Launched Ilumya® (tildrakizumab) for the treatment of plaque psoriasis, which is the first new biologics for Sun Pharma Japan in the Japanese market. |
| January, 2020 |
Merged with Pola Pharma Inc. |
| September, 2016 |
Announced the succession for manufacturing and marketing authorization for 14 long listed brands from Novartis Pharma K.K. |
| March, 2012 |
Sun Pharma Japan Limited was established in Japan |